Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies

Diğer sürümleri göster (1)

ABSTRACT Osteoporosis and cardiovascular (CV) disease share common risk factors and pathophysiology. Low bone mineral density (BMD) and fractures appear to increase the risk for multiple CV diseases. Equally, prevalent CV disease appears to predispose to bone loss and increase fracture rates. This r...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Alexander J Rodríguez, Bo Abrahamsen
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Oxford University Press 2021-07-01
Seri Bilgileri:JBMR Plus
Konular:
CARDIOVASCULAR
EVIDENCE‐BASED MEDICINE
MEDICATION SAFETY
OSTEOPOROSIS
RANDOMIZED CONTROLLED TRIALS
Online Erişim:https://doi.org/10.1002/jbm4.10522

Internet

https://doi.org/10.1002/jbm4.10522

Benzer Materyaller